2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: HPV16 is a common sexually transmitted infection although few infections lead to cervical precancer/cancer; we cannot distinguish nor mechanistically explain why only certain infections progress. HPV16 can be classified into four main evolutionary-derived variant lineages (A, B, C, D) that have been previously suggested to have varying disease risks.

          Methods: We used a high-throughput HPV16 whole-genome sequencing assay to investigate variant lineage risk among 3215 HPV16-infected women. Using sublineages A1/A2 as the reference, we assessed all variant lineage associations with infection outcome over three or more years of follow-up: 1107 control subjects (<CIN2), 906 CIN2, 1008 CIN3, 69 squamous cell carcinomas (SCC), 85 adenocarcinomas in situ (AIS), and 40 adenocarcinomas. Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). All statistical tests were two-sided.

          Results: A4 sublineage was associated with an increased risk of cancer, specifically adenocarcinoma (OR = 9.81, 95% CI = 2.02 to 47.69, P =  4.7x10 −03 ). Lineage B had a lower risk of CIN3 (OR = 0.51, 95% CI = 0. 28 to 0.91, P =  .02) while lineage C showed increased risk (OR = 2.06, 95% CI = 1.09 to 3.89, P =  .03). D2/D3 sublineages were strongly associated with an increased risk of CIN3 and cancer, particularly D2 (OR for cancer = 28.48, 95% CI = 9.27 to 87.55, P =  5.0x10 −09 ). D2 had the strongest increased risk of glandular lesions, AIS (OR = 29.22, 95% CI = 8.94 to 95.51, P =  2.3x10 −08 ), and adenocarcinomas (OR = 137.34, 95% CI = 37.21 to 506.88, P =  1.5x10 −13 ). Moreover, the risk of precancer and cancer for specific variant lineages varied by a women’s race/ethnicity; those women whose race/ethnicity matched that of the infecting HPV16 variant had an increased risk of CIN3 + ( P <  .001).

          Conclusions: Specific HPV16 variant sublineages strongly influence risk of histologic types of precancer and cancer, and viral genetic variation may help explain its unique carcinogenic properties.

          Related collections

          Author and article information

          Journal
          J Natl Cancer Inst
          J. Natl. Cancer Inst
          jnci
          JNCI Journal of the National Cancer Institute
          Oxford University Press
          0027-8874
          1460-2105
          April 2016
          28 April 2016
          28 April 2016
          : 108
          : 9
          : djw100
          Affiliations
          Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD (LM, MY, MC, JFB, NW, XZ, KY, QY, JM, DR, SB, LB, YX, MS); Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc., Frederick, MD (MY, MC, JFB, XZ, QY, JM, DR, SB, LB); Department of Microbiology, The Chinese University of Hong Kong, Hong Kong (ZC); Women’s Health Research Institute, Division of Research, Kaiser Permanente Northern California, Oakland CA (TRB); Regional Laboratory, Kaiser Permanente Northern California, Oakland, CA (TL); Department of Epidemiology and Population Health, at Albert Einstein College of Medicine, Bronx, NY (PEC, RDB); Departments of Pediatrics; Microbiology & Immunology; and, Obstetrics, Gynecology and Women's Health, at Albert Einstein College of Medicine, Bronx, NY (RDB)
          Author notes
          *Authors contributed equally to this work.
          Correspondence to: Lisa Mirabello, PhD, Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Room 6E422, Bethesda, MD 20850 (e-mail: mirabellol@ 123456mail.nih.gov ).
          Article
          PMC5939630 PMC5939630 5939630 djw100
          10.1093/jnci/djw100
          5939630
          27130930
          2a9a5bf8-21fb-4975-9114-c4c3798a3843
          Published by Oxford University Press 2016. This work is written by US Government employees and is in the public domain in the United States.
          History
          : 19 October 2015
          : 19 January 2016
          : 24 February 2016
          Page count
          Pages: 9
          Funding
          Funded by: National Institutes of Health 10.13039/100000002
          Funded by: National Cancer Institute 10.13039/100000054
          Categories
          Article

          Comments

          Comment on this article